Condition
Axillary Lymph Node Dissection
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownOmission of ALND in Breast Cancer Patients With Axillary pCRNCT05939830 · 2023-09-11
RECRUITINGNomogram to Predict Breast Cancer Related LymphedemaNCT04665882 · 2020-12-11
RECRUITINGHemopatch Versus Axillary Drainage After Axillary LymphadenectomyNCT04487561 · 2020-03-01
COMPLETEDEffect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast SurgeryNCT04029467 · 2019-07-17
UNKNOWNUpper Extremity Lymphatic Mapping for Breast Cancer PatientsNCT00717886 · 2008-06-01
COMPLETEDManual Therapy in Postoperative Breast CancerNCT01142141 · 2006-08-01
COMPLETEDCommon interventions
Aspirative drainagePROCEDURE1Axillary surgery based on lymphedema prediction nomogramPROCEDURE1DexmedetomidineDRUG1hemopatchDEVICE1isosulfan blue dyeRADIATION1manual therapy, kinesiotherapyOTHER1Regional lymph node radiotherapy (RNI) including the axillaRADIATION1Stained region Lymph Node Biopsy (SrLNB)PROCEDURE1
Leading sponsors
Trial status mix
COMPLETED3
RECRUITING2
UNKNOWN1
Phase mix
NA5
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.